{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:12:07Z","timestamp":1761747127083,"version":"build-2065373602"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BioMed Eng OnLine"],"DOI":"10.1186\/s12938-025-01461-x","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T11:57:29Z","timestamp":1761739049000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Influence of m6A regulatory factor related to immune microenvironment on the prognosis of prostate cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Wenping","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songsong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihong","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"issue":"12","key":"1461_CR1","doi-asserted-by":"publisher","first-page":"a030361","DOI":"10.1101\/cshperspect.a030361","volume":"8","author":"CH Pernar","year":"2018","unstructured":"Pernar CH, Ebot EM, Wilson KM, et al. The epidemiology of prostate cancer. Cold Spring Harb Perspect Med. 2018;8(12):a030361.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"18","key":"1461_CR2","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","volume":"79","author":"DC Hinshaw","year":"2019","unstructured":"Hinshaw DC, Shevde LA. The tumor microenvironment innately modulates cancer progression. Cancer Res. 2019;79(18):4557\u201366.","journal-title":"Cancer Res"},{"issue":"1","key":"1461_CR3","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.canlet.2019.11.009","volume":"470","author":"X Lei","year":"2020","unstructured":"Lei X, Lei Y, Li JK, et al. Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy. Cancer Lett. 2020;470(1):126\u201333.","journal-title":"Cancer Lett"},{"issue":"1","key":"1461_CR4","doi-asserted-by":"publisher","first-page":"773570","DOI":"10.3389\/fimmu.2021.773570","volume":"12","author":"L Guo","year":"2021","unstructured":"Guo L, Yang H, Zhou C, et al. N6-methyladenosine RNA modification in the tumor immune microenvironment: Novel implications for immunotherapy. Front Immunol. 2021;12(1):773570.","journal-title":"Front Immunol"},{"issue":"5","key":"1461_CR5","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1016\/j.ymthe.2021.04.009","volume":"29","author":"Y Gu","year":"2021","unstructured":"Gu Y, Wu X, Zhang J, et al. The evolving landscape of N6-methyladenosine modification in the tumor microenvironment. Mol Ther. 2021;29(5):1703\u201315.","journal-title":"Mol Ther"},{"issue":"1","key":"1461_CR6","doi-asserted-by":"publisher","first-page":"607224","DOI":"10.3389\/fonc.2021.607224","volume":"11","author":"J Hu","year":"2021","unstructured":"Hu J, Qiu D, Yu A, et al. YTHDF1 is a potential pan-cancer biomarker for prognosis and immunotherapy. Front Oncol. 2021;11(1):607224.","journal-title":"Front Oncol"},{"issue":"1","key":"1461_CR7","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.canlet.2020.12.008","volume":"500","author":"L Sun","year":"2021","unstructured":"Sun L, Zhang X, Song Q, et al. IGFBP2 promotes tumor progression by inducing alternative polarization of macrophages in pancreatic ductal adenocarcinoma through the STAT3 pathway. Cancer Lett. 2021;500(1):132\u201346.","journal-title":"Cancer Lett"},{"issue":"1","key":"1461_CR8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13046-024-03063-2","volume":"43","author":"W Xu","year":"2024","unstructured":"Xu W, Li Y, Liu L, et al. Icaritin-curcumol activates CD8+ T cells through regulation of gut microbiota and the DNMT1\/IGFBP2 axis to suppress the development of prostate cancer. J Exp Clin Cancer Res. 2024;43(1):149.","journal-title":"J Exp Clin Cancer Res"},{"issue":"16","key":"1461_CR9","doi-asserted-by":"publisher","first-page":"6145","DOI":"10.7150\/ijbs.75063","volume":"18","author":"P Li","year":"2022","unstructured":"Li P, Shi Y, Gao D, et al. ELK1-mediated YTHDF1 drives prostate cancer progression by facilitating the translation of Polo-like kinase 1 in an m6A dependent manner. Int J Biol Sci. 2022;18(16):6145\u201362.","journal-title":"Int J Biol Sci"},{"key":"1461_CR10","doi-asserted-by":"publisher","first-page":"e19819","DOI":"10.7717\/peerj.19819","volume":"13","author":"W Ying","year":"2025","unstructured":"Ying W, Ding Z, He Y, et al. Surgery, radiotherapy and endocrine therapy for oligometastatic prostate cancer efficacy: a systematic review and network meta-analysis. PeerJ. 2025;13:e19819.","journal-title":"PeerJ"},{"issue":"17","key":"1461_CR11","doi-asserted-by":"publisher","first-page":"e70989","DOI":"10.1096\/fj.202501308RR","volume":"39","author":"Y Wang","year":"2025","unstructured":"Wang Y, Cao F, Huang M, et al. Mapping a new blueprint of multimodal immunotherapy against prostate cancer: Breakthroughs, barriers, and bold frontiers. FASEB J. 2025;39(17):e70989.","journal-title":"FASEB J"},{"issue":"5","key":"1461_CR12","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.7150\/thno.52717","volume":"11","author":"W Chong","year":"2021","unstructured":"Chong W, Shang L, Liu J, et al. m6A regulator-based methylation modification patterns characterized by distinct tumor microenvironment immune profiles in colon cancer. Theranostics. 2021;11(5):2201\u201317.","journal-title":"Theranostics"},{"issue":"1","key":"1461_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12943-020-01170-0","volume":"19","author":"B Zhang","year":"2020","unstructured":"Zhang B, Wu Q, Li B, et al. m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer. Mol Cancer. 2020;19(1):53.","journal-title":"Mol Cancer"},{"issue":"1","key":"1461_CR14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12943-020-01161-1","volume":"19","author":"D Jin","year":"2020","unstructured":"Jin D, Guo J, Wu Y, et al. m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107\/LATS2-mediated YAP activity in NSCLC. Mol Cancer. 2020;19(1):40\u201340.","journal-title":"Mol Cancer"},{"issue":"22","key":"1461_CR15","doi-asserted-by":"publisher","first-page":"5447","DOI":"10.7150\/jca.35053","volume":"10","author":"L Liu","year":"2019","unstructured":"Liu L, Liu X, Dong Z, et al. N6-methyladenosine-related Genomic Targets are Altered in Breast Cancer Tissue and Associated with Poor Survival. J Cancer. 2019;10(22):5447\u201359.","journal-title":"J Cancer"},{"issue":"7743","key":"1461_CR16","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-0916-x","volume":"566","author":"D Han","year":"2019","unstructured":"Han D, Liu J, Chen C, et al. Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells. Nature. 2019;566(7743):270\u20134.","journal-title":"Nature"},{"issue":"1","key":"1461_CR17","doi-asserted-by":"publisher","first-page":"5083","DOI":"10.2147\/OTT.S249527","volume":"13","author":"Y Ma","year":"2020","unstructured":"Ma Y, Cui D, Zhang Y, et al. Insulin-like growth factor binding protein-2 promotes proliferation and predicts poor prognosis in hepatocellular carcinoma. Onco Targets Ther. 2020;13(1):5083\u201392.","journal-title":"Onco Targets Ther"},{"issue":"12","key":"1461_CR18","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1007\/s13258-021-01175-z","volume":"43","author":"W Li","year":"2021","unstructured":"Li W, Chen G, Feng Z, et al. YTHDF1 promotes the proliferation, migration, and invasion of prostate cancer cells by regulating TRIM44. Genes Genomics. 2021;43(12):1413\u201321.","journal-title":"Genes Genomics"},{"issue":"1","key":"1461_CR19","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41419-025-07648-3","volume":"16","author":"Y Shi","year":"2025","unstructured":"Shi Y, Liu B, Zhang Y, Zhao S, Zuo L, Pu J, et al. YTHDF1\/RNF7\/p27 axis promotes prostate cancer progression. Cell Death Dis. 2025;16(1):314.","journal-title":"Cell Death Dis"},{"issue":"2","key":"1461_CR20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1530\/ERC-21-0107","volume":"29","author":"CH Chau","year":"2022","unstructured":"Chau CH, Till C, Price DK, et al. Serum markers, obesity and prostate cancer risk: results from the prostate cancer prevention trial. Endocr Relat Cancer. 2022;29(2):99\u2013109.","journal-title":"Endocr Relat Cancer"},{"key":"1461_CR21","first-page":"73","volume":"2022","author":"K Borziak","year":"2022","unstructured":"Borziak K, Finkelstein J. Gene expression markers of prognostic importance for prostate cancer risk in patients with benign prostate hyperplasia. Annu Int Conf IEEE Eng Med Biol Soc. 2022;2022:73\u20136.","journal-title":"Annu Int Conf IEEE Eng Med Biol Soc"},{"issue":"11","key":"1461_CR22","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41568-020-0285-7","volume":"20","author":"D Bruni","year":"2020","unstructured":"Bruni D, Angell HK, Galon J. The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy. Nat Rev Cancer. 2020;20(11):662\u201380.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1461_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12957-021-02127-3","volume":"19","author":"X Wang","year":"2021","unstructured":"Wang X, Zhang Y, Ji Z, et al. Old men with prostate cancer have higher risk of Gleason score upgrading and pathological upstaging after initial diagnosis: a systematic review and meta-analysis. World J Surg Oncol. 2021;19(1):18.","journal-title":"World J Surg Oncol"},{"issue":"1","key":"1461_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41391-017-0024-7","volume":"21","author":"T Nordstr\u00f6m","year":"2018","unstructured":"Nordstr\u00f6m T, Akre O, Aly M, et al. Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer. Prostate Cancer Prostatic Dis. 2018;21(1):57\u201363.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"3","key":"1461_CR25","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1097\/PAI.0000000000000853","volume":"29","author":"R Guo","year":"2021","unstructured":"Guo R, Ma L, Bai X, et al. A scoring method for immunohistochemical staining on ki67. Appl Immunohistochem Mol Morphol. 2021;29(3):e20\u20138.","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"3","key":"1461_CR26","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.pathol.2024.12.633","volume":"57","author":"L Egevad","year":"2025","unstructured":"Egevad L, Micoli C, Delahunt B, et al. Gleason scores provide more accurate prognostic information than grade groups. Pathology. 2025;57(3):293\u20136.","journal-title":"Pathology"}],"container-title":["BioMedical Engineering OnLine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12938-025-01461-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12938-025-01461-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12938-025-01461-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T11:57:30Z","timestamp":1761739050000},"score":1,"resource":{"primary":{"URL":"https:\/\/biomedical-engineering-online.biomedcentral.com\/articles\/10.1186\/s12938-025-01461-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1461"],"URL":"https:\/\/doi.org\/10.1186\/s12938-025-01461-x","relation":{},"ISSN":["1475-925X"],"issn-type":[{"value":"1475-925X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"assertion":[{"value":"29 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was approved by The Ethics Committee of Zhongshan Hospital Xiamen University. Informed consent was obtained from participants for the participation in the study and all methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"124"}}